Evolus, Inc.
EOLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001570562
In the last 90 days, Evolus, Inc. insiders filed 0 open-market purchases and 1 sale; 158 institutions reported holding it in 13F filings for Q2 2026, worth $335.1M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Evolus, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 137
- +2 vs. Q2 2023
- Shares held
- 41.4M
- +4.17M (+11.2%) vs. Q2 2023
- Total value
- $378.8M
- +$107.7M (+39.7%) vs. Q2 2023
- New holders
- 15
- 63 more added
- Sold out
- 13
- 33 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EOLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 158 | $335.1M |
| Q1 2026 | 147 | $188.3M |
| Q4 2025 | 169 | $327.3M |
| Q3 2025 | 160 | $334.4M |
| Q2 2025 | 172 | $538.8M |
| Q1 2025 | 179 | $652.9M |
| Q4 2024 | 164 | $573.1M |
| Q3 2024 | 165 | $814.5M |
| Q2 2024 | 156 | $557.1M |
| Q1 2024 | 164 | $691.0M |
| Q4 2023 | 151 | $479.6M |
| Q3 2023 | 137 | $378.8M |
| Q2 2023 | 135 | $271.1M |
| Q1 2023 | 126 | $288.7M |
| Q4 2022 | 120 | $219.8M |
| Q3 2022 | 130 | $205.7M |
| Q2 2022 | 123 | $294.2M |
| Q1 2022 | 118 | $266.3M |
| Q4 2021 | 104 | $133.1M |
| Q3 2021 | 113 | $134.9M |
| Q2 2021 | 115 | $205.3M |
| Q1 2021 | 96 | $111.8M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Evolus, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Prosight Management, LP | 126,982 | $1.16M | 0.37% | +126,982 | New |
| Norges Bank | 129,100 | $1.18M | 0.00% | −35,700−21.7% | Reduced |
| JPMorgan Chase & Co | 130,900 | $1.20M | 0.00% | +96,731+283.1% | Added |
| Schonfeld Strategic Advisors LLC | 131,342 | $1.20M | 0.01% | +131,342 | New |
| Stifel Financial Corp | 141,160 | $1.29M | 0.00% | +17,812+14.4% | Added |
| CM Management, LLC | 150,000 | $1.37M | 1.45% | +75,000+100.0% | Added |
| Potomac Capital Management, Inc. | 154,847 | $1.42M | 1.82% | 00.0% | Unchanged |
| Brandywine Global Investment Management, LLC | 158,200 | $1.45M | 0.01% | +3,000+1.9% | Added |
| Bank of New York Mellon Corp | 164,020 | $1.50M | 0.00% | +17,999+12.3% | Added |
| Goldman Sachs Group Inc | 172,150 | $1.57M | 0.00% | +1,519+0.9% | Added |
| FourWorld Capital Management LLC | 245,590 | $2.24M | 0.72% | 00.0% | Unchanged |
| Essex Investment Management Co LLC | 274,804 | $2.51M | 0.41% | −3,574−1.3% | Reduced |
| Squarepoint Ops LLC | 281,744 | $2.58M | 0.01% | +139,659+98.3% | Added |
| Walleye Capital LLC | 293,084 | $2.68M | 0.04% | +256,013+690.6% | Added |
| Northern Trust Corp | 386,743 | $3.53M | 0.00% | +15,439+4.2% | Added |
| Nantahala Capital Management, LLC | 421,220 | $3.85M | 0.49% | +421,220 | New |
| D. E. Shaw & Co., Inc. | 493,681 | $4.51M | 0.01% | +334,829+210.8% | Added |
| Morgan Stanley | 526,575 | $4.81M | 0.00% | +273,426+108.0% | Added |
| Marshall Wace, LLP | 675,356 | $6.17M | 0.01% | −361,518−34.9% | Reduced |
| UBS Group AG | 774,381 | $7.08M | 0.00% | −186,064−19.4% | Reduced |
| AWH Capital, L.P. | 827,500 | $7.56M | 6.73% | +11,000+1.3% | Added |
| Geode Capital Management, LLC | 869,493 | $7.95M | 0.00% | +75,752+9.5% | Added |
| State Street Corp | 984,543 | $9.00M | 0.00% | +179,121+22.2% | Added |
| Rice Hall James & Associates, LLC | 1,105,159 | $10.1M | 0.64% | +421,890+61.7% | Added |
| Millennium Management LLC | 1,150,107 | $10.5M | 0.01% | −892,131−43.7% | Reduced |
| Boothbay Fund Management, LLC | 1,162,905 | $10.6M | 0.37% | −143,136−11.0% | Reduced |
| Nuveen Asset Management, LLC | 1,274,169 | $11.6M | 0.00% | +579,854+83.5% | Added |
| Perceptive Advisors LLC | 1,485,801 | $13.6M | 0.46% | +1,485,801 | New |
| Caligan Partners LP | 1,683,836 | $15.4M | 7.87% | −76,300−4.3% | Reduced |
| Schroder Investment Management Group | 1,752,595 | $16.0M | 0.02% | +115,647+7.1% | Added |
| Soleus Capital Management, L.P. | 2,078,000 | $19.0M | 1.91% | +1,061,000+104.3% | Added |
| Great Point Partners LLC | 2,186,934 | $20.0M | 3.76% | −247,114−10.2% | Reduced |
| First Manhattan Co | 2,287,538 | $20.9M | 0.08% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,698,647 | $24.7M | 0.00% | +741,451+37.9% | Added |
| BlackRock Inc. | 2,973,538 | $27.2M | 0.00% | −21,848−0.7% | Reduced |
| Tang Capital Management LLC | 3,097,399 | $28.3M | 3.99% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 5,179,004 | $47.3M | 15.72% | +672,807+14.9% | Added |
| Eversept Partners, LP | 0 | $0 | 0.00% | −228,679−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −203,283−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −84,000−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −53,921−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −25,369−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −16,122−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,962−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −12,039−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −10,034−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −94−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |